DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/ArsenalBio
activeFounded 2019

ArsenalBio

HQ: South San Francisco, CA, USACEO: Ken DrazanHeadcount: 200+arsenalbio.com
Funding Summary
Total Funding
$830M+
Latest Valuation
Undisclosed
About

Programmable cell therapy company writing large synthetic DNA programs into T cells for logic-gated, multi-antigen targeting of solid tumors.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →